Authorities in Delhi, India, busted a counterfeit medicine group operating out of an apartment in the Paschim Vihar area and involved fake versions of medications made by several legitimate manufacturers
Wegovy is FDA-approved for chronic weight management in adults and pediatric patients aged 12 years and older with obesity (BMI 30 kg/m for adults, 95th percentile for age and sex in pediatrics) or overweight (BMI 27 kg/m for adults, 85th percentile for pediatrics) with at least one weight-related comorbidity
HOW CAN SCULPT PRO HELP
Both authors approved the final version to be published
Key Companies: Competitive Landscape of the GLP-1 Weight Loss Drug Market Five ecosystem layers define competition in the GLP-1 Weight Loss Drug Market: approved injectable agonist brands, clinical pipeline challengers, biosimilar manufacturers, telehealth delivery platforms, and direct-to-patient manufacturer access programs
115 These results suggest that GLP-1RA might be beneficial as a therapeutic agent for treating IBD, providing a new strategy to target inflammation and improve clinical outcomes in affected patients
